Marijuana was legalised in Argentina for medical purposes in March 2017 by unanimous decision in the Senate, although the application of the law has been very slow. The National Agricultural Technology Institute (INTA), who were authorised to produce the plant, have still not started cultivation, and although it has been over a year since the law was passed it is still difficult to access the drug.
It is used primarily in palliative care to reduce pain in diseases such as arthritis and rheumatism, but also has high success rates reducing symptoms in drug-resistant epilepsy and some forms of autism. However, these benefits are yet to be proved in large-scale studies.
El Tribuno reported that INTA and the Ministry of Security will both regulate the production of the drug in order to avoid any produce going awry.
“It has the guarantee of the President, [we have] protocols to preserve and guarantee production,” assured Morales
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.